Investigators assessed the efficacy and clinical effects of ustekinumab in patients with Crohn disease who had a previously failed anti-TNF therapy attempt. Remission rates were found to be high after ...

Advances in drug delivery systems are playing an increasingly important role in the management of inflammatory bowel disease (IBD). These systems, ranging from nano-scale carriers to hydrogel-based ...

GICS 2020 Should Routine Colon Cancer Screening Start at 45, Not 50? The increase in colorectal cancer among younger adults has led to debate about lowering the age at which to begin screening.

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, ...

Please provide your email address to receive an email when new articles are posted on . Insurance-related challenges for filling prescriptions included approval delays (39.1%) and lack of coverage (29 ...

Please provide your email address to receive an email when new articles are posted on . Clinical response was noted in 47.6% of patients treated with oral vancomycin therapy for IBD associated with ...

ORLANDO -- Longer hospitalization for flares of inflammatory bowel disease (IBD) was linked to greater risk of subsequent ...

Up to 3.1 million people live with inflammatory bowel disease (IBD), which includes gastrointestinal disorders such as ulcerative colitis (UC) and Crohn’s disease that cause inflammation in the ...

Nanoparticles enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes for GI conditions like IBD through targeted delivery mechanisms. Hydrogel-based systems offer ...